(Reuters) -Swiss medical technology company Ypsomed announced on Wednesday a long-term supply deal with Novo Nordisk for autoinjectors, the latest sign of how the Danish drugmaker's weight-loss drug ...
LONDON, Nov 22 (Reuters) - Swiss medical technology company Ypsomed's (YPSN.S), opens new tab contract with Novo Nordisk includes the supply of injection pens for the Danish drugmaker's ...
Lannett has entered into an agreement with Ypsomed AG, the manufacturer and supplier of the pen injector device to be used in connection with its biosimilar insulin glargine and biosimilar insulin ...
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced ...
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare ...
Earnings call Ypsomed reported CHF 267M in core delivery systems revenue for H1 FY25/26, growing 21% YoY, with EBIT of CHF 87M and a 32.4% margin. Management reaffirmed FY guidance for ~20% revenue ...
The enhanced collaboration and innovation will improve options for pharmaceutical companies and patients requiring large-volume self-injection systems LE PONT-DE-CLAIX, France and BURGDORF, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results